Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
BBIO holding history
BridgeBio Pharma, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings
- Shares (Q2 2026)
- 499,659
- Value
- $37.2M
- % of portfolio
- 0.1%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 499,659 | $37.2M | 0.1% | −523,682−51.2% | Reduced | Holders |
| Q1 2026 | 1,023,341 | $76.0M | 0.2% | +241,996+31.0% | Added | Holders |
| Q4 2025 | 781,345 | $59.8M | 0.2% | −95,536−10.9% | Reduced | Holders |
| Q3 2025 | 876,881 | $45.5M | 0.1% | −526,860−37.5% | Reduced | Holders |
| Q2 2025 | 1,403,741 | $60.6M | 0.2% | +545,819+63.6% | Added | Holders |
| Q1 2025 | 857,922 | $29.7M | 0.1% | +857,922 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −2,804,394−100.0% | Sold out | Holders |
| Q1 2024 | 2,804,394 | $86.7M | 0.3% | −293,688−9.5% | Reduced | Holders |
| Q4 2023 | 3,098,082 | $125.1M | 0.4% | +2,303,681+290.0% | Added | Holders |
| Q3 2023 | 794,401 | $20.9M | 0.1% | +794,401 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −796,668−100.0% | Sold out | Holders |
| Q3 2021 | 796,668 | $37.3M | 0.1% | −25,350−3.1% | Reduced | Holders |
| Q2 2021 | 822,018 | $50.1M | 0.1% | −408,867−33.2% | Reduced | Holders |
| Q1 2021 | 1,230,885 | $75.8M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.